您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > GS-441524
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
GS-441524
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
GS-441524图片
CAS NO:1191237-69-0
规格:≥98%
包装与价格:
包装价格(元)
10mg电议
25mg电议
50mg电议
100mg电议
250mg电议
500mg电议
1g电议
2g电议
10g电议

产品介绍
理化性质和储存条件


Name: GS-441524
CAS#: 2378280-82-9 (HCl); 2378280-83-0 (sulfate); 1191237-69-0
Chemical Formula: C12H13N5O4
Exact Mass: 291.0968
Molecular Weight: 291.1
Storage-20℃ for 3 years in powder form
-80℃ for 2 years in solvent
Solubility (In Vitro)

DMSO: ~120 mg/mL (with ultrasonic)

Water: Insoluble
Solubility (In Vivo)
1. 10 mg/mL (34.3 mM) in 5% ethanol, 30% propylene glycol, 45% PEG 400, 20% water (pH 1.5 with HCI)

2. ≥ 2.7 mg/mL (9.4 mM) in  5% DMSO    40% PEG300    5% Tween-80    50% saline

3. ≥ 2.0 mg/mL (7.1 mM) in 10% DMSO    40% PEG300    5% Tween-80    45% saline or in in 10% DMSO    90% (20% SBE-β-CD in saline)

4. ≥ 2.0 mg/mL (7.1 mM) in 10% DMSO    90% (20% SBE-β-CD in saline)

5.  ≥ 2.0 mg/mL (7.1 mM) in  10% DMSO    90% corn oil

Technical Information

Synonym: Remdesivir metabolite; GS-441524; GS-5734 metabolite; GS 441524; GS441524; GS5734 metabolite; GS 5734 metabolite; Remdesivir-metabolite; GS-5734-metabolite; GS5734-metabolite; GS 5734-metabolite;

Chemical Name: (2R,3R,4S,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-carbonitrile
SMILES Code: N#C[C@@]1(C2=CC=C3C(N)=NC=NN32)O[C@H](CO)[C@@H](O)[C@H]1O
实验参考方法
In Vitro

In vitro activity: cells appear and grow normally at all concentrations of GS-441524 and fail to uptake the fluorescent dye CellTox Green at 24 h. The cytotoxic concentration-50% (CC50) is therefore>100 μM. The effective concentration-50% (EC50) of GS-441524 is calculated to be 0.78 μM.


Cell Assay:  To determine the toxicity of GS-441524 to CRFK cells, CRFK cells are treated with 100, 33.3, 11.1, 3.7 or 1.2 μM GS-441524 for 24 h.

In Vivo10 treated cats have a rapid response to treatment and lymphocyte levels and rectal temperatures return to pre-infection levels and levels of the two asymptomatic cats. All ten of the once or twice treated cats have remained normal to date (more than eight months post infection). Injections cause a transient 'stinging' reaction in some cats within 10 s of compound administration. Localized and transient pain is evidenced by unusual posturing, licking at the injection site and/or vocalizations that last for approximately 30-60 s after injection. Injection reactions are more pronounced in some animals relative to others and reactions are inconsistent from one injection to the next and decreas over time. Remdesivi (IV injection) in NHP results in GS-441524 being present in serum at concentrations 1000-fold higher than Remdesivir throughout a 7-day treatment course.
Animal modelCats
Formulation & Dosage5 mg/kg (Group A; n=5) or 2 mg/kg (Group B; n=5) GS-441524 SC q24 h starting three days after unequivocal clinical evidence of FIP (days 12-19 post infection).
References


[1]. The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies. Vet Microbiol. 2018 Jun;219:226-233.

[2]. What Do We Know About Remdesivir Drug Interactions? Clin Transl Sci. 2020 May 13;10.1111/cts.12815.

[3]. Advantages of the Parent Nucleoside GS-441524 over Remdesivir for Covid-19 Treatment. ACS Med. Chem. Lett. 2020.